Skip to content

Magnetic Resonance Cholangiography and Intraoperative Cholangiography in Acute Cholecystitis

Prospective Study on Impact of Preoperative Magnetic Resonance Cholangiopancreatography (MRCP) and Intraoperative Cholangiography (IOC) in Surgical Treatment of Acute Cholecystitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04059601
Enrollment
180
Registered
2019-08-16
Start date
2019-01-01
Completion date
2020-12-31
Last updated
2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis

Keywords

common bile duct stones, cholecystectomy

Brief summary

The treatment of choice for acute cholecystitis is cholecystectomy performed as soon as possible after onset of symptoms. Up to 9-22% of patients undergoing cholecystectomy due to cholecystitis have common bile duct stones. Magnetic resonance cholangiopancreatography (MRCP) can aid in technical planning of the operation. Intraoperative cholangiography (IOC) is another method to assess anatomy and stones during operation. There is a lack of quality studies comparing findings of MRCP and IOC and effect on hospital admission. The aim of this study is to systematically assess the quality of MRCP and IOC in acute cholecystitis, and observe the effect of routine MRCP on surgery outcomes, length of hospital stay, hospital admission costs, and evaluate whether routine IOC could be replaced by MRCP.

Detailed description

Background The treatment of choice for acute cholecystitis is cholecystectomy performed as soon as possible after onset of symptoms. Early cholecystectomy within 4 days after onset of symptoms resulted in reduced costs, morbidity and shorter hospital stay than delayed cholecystectomy. Preoperative magnetic resonance cholangiopancreatography ( MRCP) is usually performed if there is a clinical suspicion of common bile duct ( CBD) stones. CBD stones in acute cholecystitis can be found in up to 9-22% of cholecystectomized patients. MRCP in acute cholecystitis can aid in technical planning of laparoscopic cholecystectomy. The benefit of MRCP is the non-invasiveness of the technique with 85-95% sensitivity and 93%-97% specificity.There is a lack of good-quality prospective studies concerning the findings of MRCP and intraoperative cholangiography (IOC) in acute cholecystitis. The purpose of preoperative diagnosis of CBD stones is to facilitate adequate planning of CBD stone removal, which is preferably performed as a single-stage procedure. In acute cholecystitis the cystic duct may be obliterated and thus cause cannulation difficulties . In these situations preoperative MRCP may give valuable information if CBD stones are present. The aims of this study is: 1. To observe the feasibility of routine preoperative MRCP in acute cholecystitis in Central Finland Central Hospital 2. To study and compare the quality of MRCP and IOC in acute cholecystitis 3. To study the impact of preoperative MRCP findings in surgical outcome of laparosocpic cholecystectomy All patients with clinically and radiologically proven acute cholecystitis during one year (2019) will form the study cohort. Ultrasound and MRCP are performed unless there are no contraindications. The quality of MRCP is systematically and independently evaluated by two experienced radiologists. Laparoscopic or open cholecystectomy is programmed and IOC is performed if feasible. The quality and technical success of IOC is recorded and the c-arm cholangiography is documented and stored in the hospital database. In case of common bile duct stones the operating surgeon will decide the policy of stone removal. The onset of symptoms, hospital arrival, time from arrival to operation, laboratory values, operative details, 30 day morbidity and postoperative outcome are evaluated.

Interventions

DIAGNOSTIC_TESTMagnetic resonance cholangiography

preoperative MRCP in acute cholecystitis before cholecystectomy

Intraoperative cholangiography in acute cholecystitis during cholecystectomy

Sponsors

Jyväskylä Central Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

• Clinically and radiologically confirmed acute cholecystitis

Exclusion criteria

* Contraindication for MRCP * Patients refuses MRCP

Design outcomes

Primary

MeasureTime frameDescription
MRCP qualityHospital admissionComparing radiology interobserver findings of preoperative MRCP

Secondary

MeasureTime frameDescription
preoperative MRCP1 yearproportion of patients with bile duct stones in MRCP
Intraoperative cholangiographyDuring operationNumber of patients with bile duct stones in intraoperative cholangiography
ConversionDuring operationproportion of patients with converted laparoscopic cholecystectomy
Success of intraoperative cholangiography1 yearnumber of performed intraoperative cholangiographies
Timing of MRCPhoursTime gap between hospital admission and MRCP
Complications30 daysSurgical complications
Length of hospital staydaysnumber of days patients spent in hospital
Timing of cholecystectomyhoursTime gap between onset of symptoms and cholecystectomy

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026